OAS1 and infection: To explore whether interferon treatment could prevent or reduce infection in vitro, we treated infection-permissive intestinal cells Caco224,25 (heterozygous for OAS1 rs10774671 and rs1131454) with IFN-β or IFN-λ 4 h before or after SARS-CoV-2 infection.